CDC and FDA Investigate Drug-Resistant Salmonella Outbreak Linked to Rosabella Moringa Capsules

A February 2026 CDC and FDA investigation tied certain Rosabella moringa capsules to an extensively drug-resistant Salmonella outbreak, raising new questions about supplement supply-chain controls.

By Himiyer | March 27, 2026

Herbal wellness bottles on a table

Table of Contents

What Happened

CDC said on February 13, 2026 that federal and state officials were investigating a multistate outbreak of extensively drug-resistant Salmonella infections linked to certain lots of Rosabella brand moringa powder capsules. FDA later said the recalled product was sold nationwide and internationally through online marketplaces including Amazon, eBay, Etsy, Shein, TikTok Shop, and the brand’s own website.

Why It Matters

This was not a routine contamination notice. CDC described the outbreak strain as extensively drug-resistant, which can complicate treatment decisions for clinicians. For buyers, the case shows that botanical capsules sold online can carry food-safety and manufacturing risks that are easy to overlook.

What Buyers Should Do

Anyone with Rosabella moringa powder capsules should check the FDA recall details, compare lot codes, and stop using recalled bottles. Consumers should throw them away or return them, sanitize surfaces the product touched, and contact a healthcare provider if symptoms of Salmonella infection appear.

Sources

Bake the best cakes without the cakes.

Super amazing nice

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.